Evidence map›Paper›PMID 33630060›Full record

SynthesisRheumatology (Oxford, England)2021

Incidence and prevalence of systemic sclerosis globally: a comprehensive systematic review and meta-analysis.

Majd Bairkdar, Marios Rossides, Helga Westerlind, Roger Hesselstrand, Elizabeth V Arkema, Marie Holmqvist

Abstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Rheumatology (Oxford, England), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 107 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
107citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

107 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Precision medicine in systemic sclerosis: back to the bedside.Therapeutic advances in musculoskeletal disease · 2026
    Article
  20. A Tight Squeeze - Cardiac Tamponade in a Scleroderma Patient.Journal of community hospital internal medicine perspectives · 2026
    Article

47 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Majd BairkdarDivision of Clinical Epidemiology, Department of Medicine Solna, Karolinska Institutet, Stockholm.ORCID 0000-0001-6269-2792
Marios RossidesDivision of Clinical Epidemiology, Department of Medicine Solna, Karolinska Institutet, Stockholm.ORCID 0000-0002-9769-324X
Helga WesterlindDivision of Clinical Epidemiology, Department of Medicine Solna, Karolinska Institutet, Stockholm.ORCID 0000-0003-3380-5342
Roger HesselstrandSection for Rheumatology, Department of Clinical Sciences Lund, Lund University and Skåne University Hospital, Lund.
Elizabeth V ArkemaDivision of Clinical Epidemiology, Department of Medicine Solna, Karolinska Institutet, Stockholm.
Marie HolmqvistDivision of Clinical Epidemiology, Department of Medicine Solna, Karolinska Institutet, Stockholm.ORCID 0000-0001-8996-5260

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesWe aimed to conduct a systematic review and meta-analysis on the incidence and prevalence of SSc covering the entire literature.

methodsThis study followed the recommendations of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement of 2009. We conducted a systematic search in MEDLINE, Web of Science and Embase to identify articles reporting incidence and/or prevalence of SSc. Two authors conducted the search, reviewed articles for inclusion and extracted relevant data. We used random-effects models to estimate the pooled prevalence and incidence of SSc and performed subgroup analyses by sex, case definition and region to investigate heterogeneity. We explored the association between calendar period and reported estimates using meta-regression.

resultsAmong 6983 unique records identified, we included 61 studies of prevalence and 39 studies of incidence in the systematic review. The overall pooled prevalence of SSc was 17.6 (95% CI 15.1, 20.5) per 100 000 and the overall pooled incidence rate of SSc was 1.4 (95% CI 1.1, 1.9) per 100 000 person-years. We observed significant regional variations in reported estimates; studies conducted in North America reported considerably higher estimates than other regions. The pooled incidence and prevalence in women were five times higher than in men. More recent studies reported higher estimates than older ones.

conclusionIn this comprehensive review of the incidence and prevalence of SSc across the world, there was large heterogeneity among estimates, which should be taken into consideration when interpreting the results.

Indexed as

Asia, EasternAustraliaEuropeHumansIncidenceNew ZealandNorth AmericaPrevalenceScleroderma, SystemicSex DistributionSouth Americaincidencemeta-analysisprevalencesystematic reviewsystemic sclerosis

Identifiers

PMID33630060
PMCPMC8516513

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.